TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: cognitive impairment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Rate of hospital readmissions
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: mean myocardial MIBG uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: left ventricular end‐diastolic diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: stool fat excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: mean number of gadolinium-enhancing lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: adjusted annualized relapse rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Cumulative 5-year incidence of primary endpoint
Endpoint domain: Mortality/survival
Primary endpoint: Coronary revascularization within the first year
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Categorical pain score at 6-hour postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median glabellar line severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient assessments of looking younger
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fat content of foods consumed during television viewing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Children's BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Development of cardiorenal events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Destabilization of blood pressure control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Decline in cognitive tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Ratings of abdominal discomfort
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reduction in PPD (Probing Pocket Depth)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean total counts of bacterial species
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Procedural success with angioplasty
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative hypocalcaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Progression-Free Survival (PFS) rate at 6 months
Endpoint domain: Mortality/survival
Primary endpoint: Body Weight (BW) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent android fat change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal volitional force elicited
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived discomfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: time to onset of claudication pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of major infection
Endpoint domain: Adverse events/effects
Primary endpoint: Complete cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Treatment success (percent affected target toenail ≤10%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Thigh muscle volume decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Calf muscle volume decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Loss of strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: AOFAS-AHS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Roles-Maudsley scores of excellent and good
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: accelerated cognitive decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: N2 amplitude increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognitive restraint
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percentage of adequate UA recordings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Ease of UA assessment
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Non-Visual Acuity (NVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vision-Related Quality of Life (VRQOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: cost-effectiveness of treatments
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean PD20HS response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total efficacy of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in QIDS‐SR score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lack of efficacy discontinuations
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical adverse events discontinuations
Endpoint domain: Adverse events/effects
Primary endpoint: Gastrointestinal adverse events discontinuations
Endpoint domain: Adverse events/effects
Primary endpoint: polyp recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective ratings of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reflux symptom ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Total esophageal acid exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Total daily dose of insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 5-year primary patency rate
Endpoint domain: Mortality/survival
Primary endpoint: wall thickness after 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: analgesia-related side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Neuralgia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary emotional responses
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: overall score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of implant failure
Endpoint domain: Adverse events/effects
Primary endpoint: Arterial oxygen tension (Pa(O2))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Arterial carbon dioxide tension (Pa(CO2))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Tracheal aspirate mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clearance (CLo)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of distribution (V/F)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: M value (insulin-mediated glucose uptake)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: pain during conjunctival clamping
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: corneal toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Total body weight gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reinsertion rate of the urinary catheter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Enrollment in prevention programs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: mean nocturic episodes per night
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent of patients with a 50% or greater reduction in mean nocturic episodes per night
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: wayfinding performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postintervention confidence levels
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Positive Predictive Value (PPV) for cancer detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maintenance of nutritional status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in headache problems
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportions of patients achieving remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and rate of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Specificity for identifying UGI bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of portable endoscopy in esophageal bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of food material
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cure rates for MRSA infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Microbiologic eradication rates for MRSA infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Achieving HbA1c targets < 7.5%, < 8.0%, or ≤ 9.0%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Odds of achieving double or triple composite outcomes of HbA1c reduction without hypoglycemia and/or without weight gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fear of Cancer Recurrence (FCR)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Visual Analog Scale (VAS) for shoulder pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of future PSA testing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Occurrence of pulmonary complications
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative oxygenation index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 1-year poor outcome rate
Endpoint domain: Mortality/survival
Primary endpoint: breast-feeding duration
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cannulation success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic yield of ERCP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fat-free mass (FFM) decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resting metabolic rate (RMR) decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of delirium during hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemoglobin level ≤ 6.0 mmol/L (9.7 g/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Blood transfusion received
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: BMI reduction among overweight children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left Ventricular Myocardial Performance Index (LVMPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Peak Systolic Velocity (Sm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total systemic exposure of ICA-17043 (AUC(0-infinity))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urinary and fecal incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: skin health measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: incidence rate of pressure ulcers
Endpoint domain: Adverse events/effects
Primary endpoint: Acute rejection risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Rate of hospitalization for FR-TBI
Endpoint domain: Mortality/survival
Primary endpoint: Improvement of OCD signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in largest diameter of late enhancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Completion of advance directives
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comfort discussing advance directives
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Accuracy of cough stress test in diagnosing urodynamic stress urinary incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of adequate bowel preparations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients who ingested the entire volume of solution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Willingness to repeat the same preparation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Dietary intake of fruits and vegetables
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy intake from fat and added sugars
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Whole grain and fiber intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: combined response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feeling fatigued, weak, or tired all over
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: sufficiently physically active
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: HF hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: recurrent HF hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Safety of AS-3 RBC transfusions
Endpoint domain: Adverse events/effects
Primary endpoint: Post-transfusion blood measurements (hematocrit, pH, Na, K, Ca, lactate, glucose)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in KCCQ total scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Power Doppler score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain visual analogic scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EPR achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MODQ improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Return to normal daily activities
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Prevalence of CKD or CVD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: HbA1c concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normalization of dyslipidemic parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement of PIH on the treatment side
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life measured according to the DLQI
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean cerebral blood flow velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Leakage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absorbency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: daily frequencies of micturition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: voiding volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: mean duration of intervals between micturition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Chorioamnionitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: remission of PTSD diagnoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of PTSD diagnoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of major postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Comfort of devices
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Plasma elimination half-life of oxycodone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Haemodialysis clearance of oxycodone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of cesarean section
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: peak relative oxygen uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: long term mortality
Endpoint domain: Mortality/survival
Primary endpoint: Enrollment in drug treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Community recovery outcomes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rivermead Mobility Index (RMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reversals of soft PRCL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ECM mean log10 resistance values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tooth sensitivity reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfying erections and coitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attendance rate
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Antihypertensive effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adherence to evidence-based practices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Chronotropic Response (CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ΔHRR1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ΔHRR2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in muscle damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Reduction in strength after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: OSAS-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: live birth rate per embryo transfer
Endpoint domain: Mortality/survival
Primary endpoint: therapy completion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: therapy failure rate
Endpoint domain: Adverse events/effects
Primary endpoint: serious drug-related side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Obstructive coronary artery disease prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Referral for catheterization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Statin use when indicated
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ΔFMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: [11C]raclopride binding values in the ventral limbic striatum and putamen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: neuropsychological assessments of memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: delayed recall for words and figures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: everyday memory functioning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Patient understanding of proposed treatment plan
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of pharyngeal dysfunction with laryngeal bolus penetration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper esophageal sphincter resting tone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper esophageal sphincter peak contraction amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose of salbutamol required to increase heart rate by 40 beats/min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes